FDA Authorizes Lower Dose of COVID-19 Antibody Therapy REGEN-COV

The FDA has updated the Emergency Use Authorization for REGEN-COV (casirivimab and imdevimab) lowering the dose to 1200mg to treat COVID-19.

Read the full article here

Related Articles